Specific receptor sites for platelet activating factor on rat liver plasma membranes
- PMID: 2821908
- DOI: 10.1016/0003-9861(87)90574-1
Specific receptor sites for platelet activating factor on rat liver plasma membranes
Abstract
The binding of 3H-labeled 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF) to isolated rat liver plasma membranes and its inhibition by PAF agonists and receptor antagonists was demonstrated. The specific binding was readily saturable with a high affinity. The equilibrium dissociation constant (KD) value was 0.51 (+/- 0.14) nM and the maximal number of binding sites (Bmax) was estimated to be 141 (+/- 18) fmol/mg protein. The binding site was PAF specific-biologically inactive enantiomer was practically inactive. Two PAF-like receptor antagonists, Ono-6240 and CV-3988, and two PAF-unlike receptor antagonists, L-652,731 and kadsurenone, also displaced the binding of [3H]PAF to rat liver plasma membranes but their relative potencies in this system differed from those found in other receptor systems. Mg2+ potentiated [3H]PAF binding but inhibited it at concentrations higher than 10 mM. Both Na+ and K+ inhibited the Mg2+-potentiated binding, an ionic effect which was different from that found in rabbit platelets. These results suggest that rat livers contain PAF-specific receptors, and the receptors in rat livers are different from those found in other receptor systems.
Similar articles
-
Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.Biol Reprod. 1989 Oct;41(4):587-603. doi: 10.1095/biolreprod41.4.587. Biol Reprod. 1989. PMID: 2559778
-
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.J Biol Chem. 1986 Oct 15;261(29):13720-6. J Biol Chem. 1986. PMID: 3020044
-
High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.Mol Pharmacol. 1988 Aug;34(2):145-51. Mol Pharmacol. 1988. PMID: 2842653
-
L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.Lipids. 1991 Dec;26(12):1148-53. doi: 10.1007/BF02536520. Lipids. 1991. PMID: 1668109 Review.
-
Platelet-activating factor receptor.Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:599-609. doi: 10.1016/s0090-6980(02)00058-8. Prostaglandins Other Lipid Mediat. 2002. PMID: 12432946 Review.
Cited by
-
Effect of platelet-activating factor on lipoprotein lipase and blood lipids.Lipids. 1991 Dec;26(12):1102-7. doi: 10.1007/BF02536510. Lipids. 1991. PMID: 1819694
-
Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers.Biochem J. 1994 Nov 1;303 ( Pt 3)(Pt 3):795-802. doi: 10.1042/bj3030795. Biochem J. 1994. PMID: 7526847 Free PMC article.
-
Characterization of the binding of plasminogen activators to plasma membranes from human liver.Biochem J. 1992 Nov 1;287 ( Pt 3)(Pt 3):911-5. doi: 10.1042/bj2870911. Biochem J. 1992. PMID: 1445249 Free PMC article.
-
Roles of Ca2+ in human neutrophil responses to receptor agonists.Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):705-11. doi: 10.1042/bj2770705. Biochem J. 1991. PMID: 1651699 Free PMC article.
-
Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.Biochem J. 1990 May 1;267(3):647-52. doi: 10.1042/bj2670647. Biochem J. 1990. PMID: 2160232 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources